Skip to main content
. 2019 Jan 1;9(2):540–553. doi: 10.7150/thno.28374

Figure 9.

Figure 9

Association between mutated genes involved in the cereblon pathway and resistance to Pomalidomide. (A) Representation of mutated genes involved in IMiD-mediated CRL4CRBN activity. Mutated genes are shown in filled ellipses. (B) Seven HMCLs presenting missense mutations of genes involved in the cereblon pathway as well as six HMCLs without mutations (WT) have been treated with Pomalidomide. IC50 of Pomalidomide for each tested HMCL is shown in the table below the heatmap. IC50 of mutated (Mut) and wild type (WT) HMCLs were compared using Wilcoxon test. * : p-value < 0.05. Error bars represent mean standard deviation.